March 29, 2025 - 13:16

Toronto, March 28, 2025 – Helios Fairfax has released its financial results for the fourth quarter of 2024, showcasing a strong performance despite ongoing market challenges. The company reported significant growth in revenue, driven by strategic investments and operational efficiencies.
During this period, Helios Fairfax achieved a notable increase in net income, reflecting effective cost management and a commitment to enhancing shareholder value. The company's diversified portfolio contributed to its resilience, allowing it to navigate fluctuations in the economic landscape.
Management highlighted the successful implementation of new initiatives aimed at expanding market reach and improving customer engagement. These efforts have positioned the company well for future growth, as it continues to explore opportunities in emerging markets.
Looking ahead, Helios Fairfax remains optimistic about its prospects for 2025, focusing on innovation and sustainability to drive long-term success. The company is dedicated to delivering value to its stakeholders while maintaining a strong commitment to corporate responsibility.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...